BBIO logo

BridgeBio Pharma, Inc. (BBIO)

Profile

Full Name

BridgeBio Pharma, Inc.

Ticker

NASDAQ: BBIO

Exchange

NASDAQ

Country

United States

IPO

June 27, 2019

Indexes

Not included

Employees

725

Key Details

Price

$45.94(+0.61%)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$221.90M(+2285.27% YoY)

Annual EPS

-$2.88(+27.09% YoY)

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
See Full Chart & Historical Data

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Jul 14, 25 Piper Sandler
Overweight
Jul 14, 25 Jefferies
Buy
Jul 11, 25 Citigroup
Buy
Jul 9, 25 Oppenheimer
Outperform
Jun 30, 25 Wells Fargo
Overweight
Jun 25, 25 B of A Securities
Buy
Jun 17, 25 Wolfe Research
Outperform
Jun 9, 25 HC Wainwright & Co.
Buy
Apr 30, 25 UBS
Buy
Apr 30, 25 Scotiabank
Sector Outperform

Institutional Ownership

  • What is the ticker symbol for BridgeBio Pharma, Inc.?
  • Does BridgeBio Pharma, Inc. pay dividends?
  • What sector is BridgeBio Pharma, Inc. in?
  • What industry is BridgeBio Pharma, Inc. in?
  • What country is BridgeBio Pharma, Inc. based in?
  • When did BridgeBio Pharma, Inc. go public?
  • Is BridgeBio Pharma, Inc. in the S&P 500?
  • Is BridgeBio Pharma, Inc. in the NASDAQ 100?
  • Is BridgeBio Pharma, Inc. in the Dow Jones?
  • When was BridgeBio Pharma, Inc.'s last earnings report?
  • When does BridgeBio Pharma, Inc. report earnings?

What is the ticker symbol for BridgeBio Pharma, Inc.?

The ticker symbol for BridgeBio Pharma, Inc. is NASDAQ:BBIO

Does BridgeBio Pharma, Inc. pay dividends?

No, BridgeBio Pharma, Inc. does not pay dividends

What sector is BridgeBio Pharma, Inc. in?

BridgeBio Pharma, Inc. is in the Healthcare sector

What industry is BridgeBio Pharma, Inc. in?

BridgeBio Pharma, Inc. is in the Biotechnology industry

What country is BridgeBio Pharma, Inc. based in?

BridgeBio Pharma, Inc. is headquartered in United States

When did BridgeBio Pharma, Inc. go public?

BridgeBio Pharma, Inc.'s initial public offering (IPO) was on June 27, 2019

Is BridgeBio Pharma, Inc. in the S&P 500?

No, BridgeBio Pharma, Inc. is not included in the S&P 500 index

Is BridgeBio Pharma, Inc. in the NASDAQ 100?

No, BridgeBio Pharma, Inc. is not included in the NASDAQ 100 index

Is BridgeBio Pharma, Inc. in the Dow Jones?

No, BridgeBio Pharma, Inc. is not included in the Dow Jones index

When was BridgeBio Pharma, Inc.'s last earnings report?

BridgeBio Pharma, Inc.'s most recent earnings report was on April 29, 2025

When does BridgeBio Pharma, Inc. report earnings?

The next expected earnings date for BridgeBio Pharma, Inc. is August 5, 2025
On this page